The murine mammary tumor induced by PyMT shares many features with poor-prognosis human breast cancer such as a high frequency of distant metastases, persistent expression of biomarkers, ErbB2/Neu and cyclin D1, and loss of estrogen and progesterone receptor expression [28]. This evidence concerns the gene PGR and breast cancer.